Cardiology

Ticagrelor, prasugrel compared in ACS treated with PCI

(HealthDay)—For patients presenting with acute coronary syndrome (ACS) who undergo percutaneous coronary intervention (PCI), a postrandomization subgroup analysis suggests that a prasugrel-based strategy is superior to ...

page 7 from 35